BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 24232870)

  • 1. Advanced imaging of cardiac sarcoidosis.
    Schatka I; Bengel FM
    J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by
    Sasson SC; Russo R; Chung T; Chu G; Hunyor I; Williamson J; Murad A; Kane A; Riminton S; Limaye S
    J Med Case Rep; 2017 Oct; 11(1):291. PubMed ID: 29052526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of cardiac sarcoid lesions with (18)F-fluoro-2-deoxyglucose positron emission tomography.
    Ohira H; Tsujino I; Sato T; Yoshinaga K; Manabe O; Oyama N; Nishimura M
    Intern Med; 2011; 50(11):1207-9. PubMed ID: 21628936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.
    White JA; Rajchl M; Butler J; Thompson RT; Prato FS; Wisenberg G
    Circulation; 2013 Jun; 127(22):e639-41. PubMed ID: 23733970
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of PET in Cardiac Sarcoidosis.
    Smedema JP; van Kroonenburgh MJ; Snoep G; Bekkers SC; Gorgels AP
    J Nucl Med; 2004 Nov; 45(11):1975. PubMed ID: 15534072
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
    Ishimaru S; Tsujino I; Sakaue S; Oyama N; Takei T; Tsukamoto E; Tamaki N; Nishimura M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):234-5. PubMed ID: 16315788
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.
    Sharp MB; Soufer A; Abdelmessih M; Rosenfeld LE; Baldassarre LA; Miller EJ
    J Nucl Cardiol; 2020 Apr; 27(2):688-690. PubMed ID: 30737635
    [No Abstract]   [Full Text] [Related]  

  • 13. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
    Ricci F; Mantini C; Grigoratos C; Bianco F; Bucciarelli V; Tana C; Mastrodicasa D; Caulo M; Donato Aquaro G; Raffaele Cotroneo A; Gallina S
    Curr Med Imaging Rev; 2019; 15(1):10-20. PubMed ID: 31964322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
    Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
    Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
    Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
    J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.
    Pandya C; Brunken RC; Tchou P; Schoenhagen P; Culver DA
    Eur Respir J; 2007 Feb; 29(2):418-22. PubMed ID: 17264327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cardiac sarcoidosis with advanced imaging modalities.
    Orii M; Imanishi T; Akasaka T
    Biomed Res Int; 2014; 2014():897956. PubMed ID: 25250336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis.
    Divakaran S; Stewart GC; Lakdawala NK; Padera RF; Zhou W; Desai AS; Givertz MM; Mehra MR; Kwong RY; Hedgire SS; Ghoshhajra BB; Taqueti VR; Skali H; Dorbala S; Blankstein R; Di Carli MF
    Circ Cardiovasc Imaging; 2019 Jun; 12(6):e008975. PubMed ID: 31177817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.